Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01090739 · ClinicalTrials.gov registry record · NA
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
A NA study, sponsored by ASTORA Women's Health.
- Completed
- Registry status
- NA
- Development phase
- 207
- Enrollment target
NCT01090739 is a NA study that has completed, run by ASTORA Women's Health. The registered enrollment target is 207 participants.
The verdict
NCT01090739, a NA study, has completed, sponsored by ASTORA Women's Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 207 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that the TOPAS System effectively treats fecal incontinence in women as measured by a 50% reduction in the number of FI episodes in a 14 day bowel diary at 12 months.
Interventions
- DEVICE TOPAS Treatment for Fecal Incontinence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2010-04 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01090739
The ClinicalTrials.gov registry entry for NCT01090739 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ASTORA Women's Health, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TOPAS Treatment for Fecal Incontinence is the first listed.
NCT01090739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01090739 about?
NCT01090739 is a clinical study titled "Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence". The purpose of this study is to demonstrate that the TOPAS System effectively treats fecal incontinence in women as measured by a 50% reduction in the number of FI episodes in a 14 day bowel diary at 12 months.
What is the current status of trial NCT01090739?
This trial is currently completed. It is a NA study. The enrollment target is 207 participants. The study started on 2010-04. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01090739?
The interventions under investigation include: TOPAS Treatment for Fecal Incontinence (DEVICE).
Who is sponsoring clinical trial NCT01090739?
This trial is sponsored by ASTORA Women's Health, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.